CS logo
small CS logo
Our Lady of Mercy Medical Center

Bronx, New York, United States
Doctor in the Bronx, New York
600 E 233rd St, Bronx, NY 10466

About Our Lady of Mercy Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
CTI BioPharma
3
Favrille
2
Amgen
1
Biogen
1
Genentech, Inc.
1
Loyola University
1
Maxim Pharmaceuticals
1
NCIC Clinical Trials Group
1
Novartis Pharmaceuticals
1
Our Lady of Mercy Medical Center
1
Total Rows: 10

Clinical Trials at Our Lady of Mercy Medical Center


During the past decade, Our Lady of Mercy Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer
1997-06-01
2002-08-01
Completed
69
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
1997-11-01
Unknown status
60
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
1998-07-01
2011-08-01
Completed
360
CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
1998-12-01
2005-01-01
Terminated
80
Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1999-12-01
Unknown status
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
2000-12-04
2014-03-17
Completed
2,104
EPO906 Therapy in Patients With Advanced Kidney Cancer
2002-04-01
Completed
53
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
2001-03-01
Unknown status
22

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Our Lady of Mercy Medical Center" #1 sponsor was "CTI BioPharma" with 3 trials, followed by "Favrille" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Biogen" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Our Lady of Mercy Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Chiron Corporation" with 1 trials as a collaborator, "North Central Cancer Treatment Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCTI BioPharma: 3CTI BioPharma: 3Favrille: 2Favrille: 2Amgen: 1Amgen: 1Biogen: 1Biogen: 1Genentech, Inc.: 1Genentech, Inc.: 1Loyola University: 1Loyola University: 1Maxim Pharmaceuticals: 1Maxim Pharmaceuticals: 1NCIC Clinical Trials Group: 1NCIC Clinical Trials Group: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1Our Lady of MercyMedical Center: 1Our Lady of MercyMedical Center: 1

Created with Highcharts 11.1.0Top CollaboratorsCancer and LeukemiaGroup B: 1Cancer and LeukemiaGroup B: 1Chiron Corporation: 1Chiron Corporation: 1North Central CancerTreatment Group: 1North Central CancerTreatment Group: 1SWOG Cancer ResearchNetwork: 1SWOG Cancer ResearchNetwork: 1

Clinical Trials Conditions at Our Lady of Mercy Medical Center


According to Clinical.Site data, the most researched conditions in "Our Lady of Mercy Medical Center" are "Leukemia" (2 trials), "Lymphoma" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Breast Cancer" (1 trials) and "Diffuse Large-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Our Lady of Mercy Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Our Lady of Mercy Medical Center


Most popular intervention types in "Our Lady of Mercy Medical Center" are "Drug" (11 trials) and "Biological" (5 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "filgrastim" (2 trials), "paclitaxel" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Our Lady of Mercy Medical Center


The vast majority of trials in "Our Lady of Mercy Medical Center" are 10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Our Lady of Mercy Medical Center


Currently, there are NaN active trials in "Our Lady of Mercy Medical Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Our Lady of Mercy Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Our Lady of Mercy Medical Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 8Phase 2: 8Phase 3: 4Phase 3: 4Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Unknown status: 4Unknown status: 4Terminated: 2Terminated: 2